Press Releases Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 03:59:59 2025-01-29 pm EST			5-day change	1st Jan Change
0.0500 ^CAD	+42.86%		-.--%	+25.00%

Mar. 20	Numinus Wellness Inc. Announces Its Psychedelic-Assisted Therapy Training Program Has Been Officially Approved by the State of Colorado	CI
Mar. 20	Numinus Wellness Brief: Says Approved as a State-Certified Natural Medicine Training Program in Colorado	MT

Press Releases

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado	Mar. 20	AQ
Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries	Feb. 17	AQ
Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries	Feb. 14	AQ
Canadian Investment Regulatory Organization Trading Halt - NUMI	Jan. 30	AQ
Numinus Wellness Announces Cease Trade Order and Provides Corporate Update	Jan. 30	AQ
Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care	Dec. 17	PR
Numinus Applies for Management Cease Trade Order	Nov. 15	AQ
Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care	Nov. 15	PR
Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD	24-08-12	AQ
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results	24-07-11	PR
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results	24-07-11	AQ
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024	24-07-10	AQ
Numinus Wellness Announces Resignation of Director	24-06-24	PR
Numinus Wellness Announces Resignation of Director	24-06-24	AQ
MedBright AI Announces Strategic Acquisition by Numinus Wellness	24-06-20	AQ
Numinus Wellness Announces Strategic Acquisition of MedBright AI	24-06-20	PR
Numinus Clarifies Disclosures	24-06-07	NE
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD	24-06-07	AQ
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders	24-05-31	AQ
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders	24-05-31	PR
Numinus Wellness Charts Path To Profitability While Strengthening Community Ties	24-05-30	NE
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder	24-05-30	NE
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy	24-05-30	AQ
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support	24-05-07	AQ
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003	24-04-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Press Releases

Filters